Symbiotec Pharmalab IPO
Symbiotec Pharmalab Limited (SYMBIOTEC) · mainboard IPO on NSE and BSE · Book Building. Listed on 01 September 2026.
Issue details
Listing day
Back-tested estimate (from a model that had only seen earlier years' IPOs): listing gain +24.6% (likely range +13% to +45%), day's high +32.2%, chance of a gain 92%. Actual: 0.0% at the open, +19.4% at the high.
Subscription status
| Category | Shares offered | Shares bid for | Subscribed | |
|---|---|---|---|---|
| QIB (institutions) | 37,39,872 | 64,33,59,195 | 172x | |
| NII (HNI) total | 28,04,904 | 20,65,35,120 | 73.6x | |
| Big NII (above ₹10 lakh) | 18,69,936 | 15,50,46,495 | 82.9x | |
| Small NII (₹2-10 lakh) | 9,34,968 | 5,14,88,625 | 55.1x | |
| Retail | 65,44,776 | 8,48,10,330 | 13.0x | |
| Employees | 35,377 | 5,45,055 | 15.4x | |
| Total | 1,31,24,929 | 93,52,49,700 | 71.3x |
Bids on NSE and BSE together, as published by NSE, as of 27 Aug 2026, 07:00 PM. Shares offered exclude the anchor portion. 8% of all shares bid for were at the cut-off price.
Past IPOs with similar demand
Earlier mainboard IPOs whose QIB, NII and retail subscription and size were closest to Symbiotec Pharmalab's, and how they listed.
| IPO | QIB | NII | Retail | Total | Size | Listing gain | Day high |
|---|---|---|---|---|---|---|---|
| Lalithaa Jewellery MartAug 2026 | 145x | 73.9x | 11.8x | 63.0x | ₹1,799 Cr | +31.8% | +36.5% |
| Tata TechnologiesNov 2023 | 203x | 62.1x | 16.5x | 69.4x | ₹3,043 Cr | +140.0% | +180.0% |
| INOX IndiaDec 2023 | 148x | 53.2x | 15.3x | 61.3x | ₹1,459 Cr | +43.9% | +50.0% |
| Happy ForgingDec 2023 | 220x | 62.2x | 15.1x | 82.0x | ₹1,006 Cr | +17.6% | +27.9% |
| TruAlt BioenergySep 2025 | 159x | 98.6x | 11.0x | 71.9x | ₹874 Cr | +10.0% | +10.7% |
| P N Gadgil JewellersSep 2024 | 137x | 56.1x | 16.6x | 59.4x | ₹1,158 Cr | +72.9% | +76.7% |
Lead managers and their listing record
| Book running lead manager | Mainboard IPOs since 2019 | Avg listing gain | Listed at a premium |
|---|---|---|---|
| JM Financial | 109 | +22.8% | 75% |
| Avendus Capital | 9 | +8.6% | 67% |
| Motilal Oswal Investment Advisors | 47 | +15.0% | 72% |
| Nomura Financial Advisory and Securities (India) | 27 | +16.0% | 56% |
Offer documents (NSE)
Frequently asked
What is the Symbiotec Pharmalab IPO price band and lot size? ₹938–988 per share, with a lot of 15 shares, so the smallest retail bid is ₹14,820.
How many times has it been subscribed? 71.3x overall: QIB 172x, NII 73.6x, retail 13.0x, employees 15.4x.
How did it list? It opened at ₹988, +0.0% against the issue price of ₹988, and closed its first day +11.1%.
